Gemcitabine-based combination treatment of pancreatic cancer-Reference-Cited by-同舟云学术

Gemcitabine-based combination treatment of pancreatic cancer

Published:2002-02 Issue:1 Volume:29 Page:25-35
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Heinemann Volker

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference48 articles.

1. Gemcitabine: Progress in the treatment of pancreatic cancer;Heinemann;Oncology,2001

2. A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin;Cullinan;Cancer,1990

3. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial;Burris;J Clin Oncol,1997

4. Efficacy of 5-FU + cisplatin (FUP) compared to bolus 5-FU (FU) in advanced pancreatic carcinoma (APC): A randomized trial from the French Anticancer Centers Digestive Group (FNLCCDG);Rougier;Proc Am Soc Clin Oncol,1999

5. Phase II study of gemcitabine in patients with advanced pancreatic cancer;Carmichael;Br J Cancer,1996

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gemcitabine and rapamycin-loaded mixed polymeric thermogel for metastatic pancreatic cancer therapy;Journal of Controlled Release;2023-08

2. Antiproliferative Activity of Krukovine by Regulating Transmembrane Protein 139 (TMEM139) in Oxaliplatin-Resistant Pancreatic Cancer Cells;Cancers;2023-05-07

3. Periplocin exerts antitumor activity by regulating Nrf2-mediated signaling pathway in gemcitabine-resistant pancreatic cancer cells;Biomedicine & Pharmacotherapy;2023-01

4. Gemcitabine in combination with epibrassinolide enhanced the apoptotic response in an ER stress-dependent manner and reduced the epithelial-mesenchymal transition in pancreatic cancer cells;Turkish Journal of Biology;2022-01-01

5. Understanding the Mechanism of Cell Death in Gemcitabine Resistant Pancreatic Ductal Adenocarcinoma: A Systems Biology Approach;Current Genomics;2020-01-01